다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) 뉴스

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:TEVA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/17	21:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	21:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/14	20:21	IH Market News	Adobe Soars 15% Pre-Market; Visa and Mastercard Encounter Hurdles in $30 Billion Agreement, and More	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/05	05:05	Business Wire	Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/02	03:25	Business Wire	New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/02	03:20	Business Wire	Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/30	07:38	Business Wire	Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/21	09:25	GlobeNewswire Inc.	Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/21	09:25	Business Wire	Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/15	21:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/15	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/15	21:15	Business Wire	Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/09	20:53	IH Market News	Bain Capital in Talks to Acquire PowerSchool; Blackstone Emerges Victorious in Hipgnosis Bidding War, and More News	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/08	20:00	Business Wire	Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/08	19:30	Business Wire	Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/03	07:30	Business Wire	Teva to Present at the 2024 Bank of America Healthcare Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/02	21:30	Business Wire	Teva’s 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/04/30	17:00	GlobeNewswire Inc.	U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/04/30	17:00	Business Wire	U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/04/17	06:43	Business Wire	Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/04/17	06:30	GlobeNewswire Inc.	Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/04/16	21:00	Business Wire	Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/04/11	21:30	Business Wire	Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China	NYSE:TEVA	Teva Pharmaceutical Industries Ltd

검색 관련기사 보기:NYSE:TEVA

1 2 3 4 5 6 7 8 9 10 다음 >>

Gold vs US Dollar

Invesco QQQ Trust Series 1

Verizon Communications

Energy Select Sector SPDR

American Express

US Dollar vs Sterling

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관